Price $24.56 |
Market Cap
277.8M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.13
|
P/S
1.91
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-8.7K
|
FCF
-1.0
|
|
Op. Margin
-17.70%
|
Net Margin
-13.70%
|
ROE
-7.90%
|
ROI
-5.40%
|
|
ROA
-6.50%
|
EPS Growth
-99.10%
|
Current Ratio
6.1
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| STRATA Skin Sciences Inc (SSKN) | $3.09 | - | - | 16.4M | Strong Buy |
| Chromadex Corp (CDXC) | $3.26 | - | - | 105.8M | Strong Buy |
| Rockwell Medical Inc (RMTI) | $3.04 | - | - | 55M | Strong Buy |
| China SXT Pharmaceuticals Inc (SXTC) | $0.59 | - | - | 1.2M | Strong Buy |
| Omnicell Inc (OMCL) | $44.48 | - | - | 1.32B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
